Business news

CanniMed Therapeutics Inc. reports financial results for Q3 2017

Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017.

Tremendous opportunity in legal cannabis market

Tremendous opportunity in legal cannabis market

Companies need to start thinking about the therapeutic benefits

Is GW Pharma now the future of cannabis-based drugs?

GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) shares initially jumped Monday after disappointing data from a leading drug candidate sent shares of Zynerba Pharmaceuticals Inc

Creso Pharma sign exclusive agreement with Virbac

The Swiss launch of CPH’s proprietary formulated hemp-based complementary feed products for companion animals, anibidiol® 1.25 and anibidiol® 2.5, is planned for the fourth quarter of this year.


Company Developing Cannabinoid-Based Drug Therapy for Concussions Completes Reverse Takeover

A preclinical research and development company that is developing a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury, has just completed a reverse takeover.

An advisor's guide to the cannabis industry

Investors looking to take a flyer on the “budding” industry need to understand that risks go up when companies “touch the plant.” Safer plays are further down the supply chain.

Creso Pharma acquires Canadian-based Mernova Medicinal

Executive Chairman and Co-Founder Boaz Wachtel and Chief Operating Officer David Russell talk about the strategic advantages and plans for Canadian-based Mernova Medicinal.

Avicanna bid to join Johnson & Johnson cannabis innovation successful

As medical cannabis takes off around the world, Avicanna is the latest company to join the big boys in a very special innovation

Better Buy: Cara Therapeutics Inc. vs. GW Pharmaceuticals

Both of these fledgling drugmakers have cannabinoids in their pipelines, but they're far more attractive than your average marijuana stock. Find out which one stands tallest when stacked side by side.

Why medical cannabis Is slow in coming to Europe

Drug policy usually moves like an iceberg: slowly. And while and it can be hard to turn, sometimes it changes course in an unexpected direction.